Free Trial

Rep. Julie Johnson Sells Procter & Gamble Company (The) (NYSE:PG) Shares

Procter & Gamble logo with Consumer Staples background

Key Points

  • Representative Julie Johnson sold shares of Procter & Gamble (NYSE:PG) worth between $1,001 and $15,000 on August 14th, as disclosed in a filing on September 11th.
  • Procter & Gamble reported $20.89 billion in revenue for the last quarter, exceeding analyst expectations and showing a 1.7% year-over-year increase.
  • The company's quarterly dividend was recently paid at a rate of $1.0568 per share, yielding approximately 2.7% annually, with a payout ratio of 64.98%.
  • Five stocks to consider instead of Procter & Gamble.

Representative Julie Johnson (D-Texas) recently sold shares of Procter & Gamble Company The) (NYSE: PG. In a filing disclosed on September 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on August 14th. The trade occurred in the Representative's "CHASE BROKERAGE ACCOUNT (3935)" account.

Representative Julie Johnson also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of McDonald's NYSE: MCD on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Parker-Hannifin NYSE: PH on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Charles Schwab NYSE: SCHW on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Fidelity National Information Services NYSE: FIS on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of ConocoPhillips NYSE: COP on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Home Depot NYSE: HD on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Dover NYSE: DOV on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 8/14/2025.

Procter & Gamble Price Performance

PG traded down $0.61 on Friday, hitting $158.02. 5,956,120 shares of the company's stock were exchanged, compared to its average volume of 6,033,143. Procter & Gamble Company has a fifty-two week low of $149.91 and a fifty-two week high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a 50-day moving average price of $156.21 and a 200-day moving average price of $161.84. The stock has a market cap of $369.85 billion, a price-to-earnings ratio of 24.27, a P/E/G ratio of 4.19 and a beta of 0.36.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. During the same quarter in the previous year, the company posted $1.40 EPS. The firm's quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's payout ratio is 64.98%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of the business's stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the sale, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. This represents a 22.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Sundar G. Raman sold 9,554 shares of the business's stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,511,060.64. Following the sale, the chief executive officer owned 41,886 shares in the company, valued at $6,624,689.76. This trade represents a 18.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 120,181 shares of company stock valued at $18,918,012. 0.20% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on PG. Evercore ISI reaffirmed an "in-line" rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Wells Fargo & Company lowered their price target on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. UBS Group set a $180.00 price target on shares of Procter & Gamble and gave the company a "buy" rating in a research report on Wednesday, July 30th. Finally, Barclays set a $164.00 price target on shares of Procter & Gamble and gave the company an "equal weight" rating in a research report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $175.12.

Get Our Latest Analysis on Procter & Gamble

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Benjamin Edwards Inc. lifted its position in Procter & Gamble by 120.7% in the first quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company's stock valued at $62,098,000 after buying an additional 199,258 shares during the last quarter. Capital Investment Advisory Services LLC lifted its position in Procter & Gamble by 13.8% in the first quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock valued at $6,426,000 after buying an additional 4,562 shares during the last quarter. World Investment Advisors lifted its position in Procter & Gamble by 6.0% in the first quarter. World Investment Advisors now owns 50,913 shares of the company's stock valued at $8,677,000 after buying an additional 2,886 shares during the last quarter. Concurrent Investment Advisors LLC lifted its position in Procter & Gamble by 26.4% in the first quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company's stock valued at $20,451,000 after buying an additional 25,059 shares during the last quarter. Finally, Kelly Financial Services LLC lifted its position in Procter & Gamble by 8.7% in the first quarter. Kelly Financial Services LLC now owns 1,727 shares of the company's stock valued at $294,000 after buying an additional 138 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024. Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.

About Procter & Gamble

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The AI-Proof Portfolio: 3 Stocks You Need to See
Markets Brace for Fed: What Investors Need to Know Before Wednesday
3 Biotech Stocks Under $5 With Huge Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines